Do you want to read an article? Please log in or register.
Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies
Asthma
Related content
RECOMMENDED
AsthmaRespiratory Tract Infection
Efficacy of biologic agents in patients with comorbid asthma and chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir Rev
Kyriakopoulos C, Ntritsos G, Gogali A, Papanikolaou A, Angelopoulos V, Oikonomou ED, Kostikas K
doi: 10.1183/16000617.0186-2025
COMMENTED
Asthma
A self-controlled case series to evaluate the effects of clinical trial eligibility criteria on biologic-associated reductions in severe asthma exacerbations: an analysis of the CHRONICLE Study
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Boakye-Dankwa E, Kiddle SJ, Koo HN, Harper AR, Ambrose CS, Douglas IJ, Quint JK
doi: 10.1183/13993003.02196-2025
COMMENTED
Respiratory Tract Infection
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
De Corso E, Canonica GW, Heffler E, Springer M, Grzegorzek T, Viana M, Horváth Z, Mullol J, Gevaert P, Michel J, Peters AT, Wagenmann M, Zaghloul S, Zhang M, Corbett M, Nash S, Angello JT, Radwan A, Deniz Y, Martin A, Hellings PW
doi: 10.1016/S2213-2600(25)00287-5
Asthma
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study
Lancet Respir Med
Logan J, Martin K, Gillespie L, McConnachie A, Lee WN, Burhan H, Brown T, Faruqi S, Jackson DJ, Kurukulaaratchy R, Mansur AH, Saralaya D, Fowler SJ, Patel P, Brown J, Lordan J, Siddiqui S, Smith SJ, Shah PA, Haldar K, Megremis S, Harrison SA, Brown R, Nelson C, Mistry V, Brown V, Chalmers JD, Djukanovic R, Pavord ID, Heaney LG, Brightling CE, Chaudhuri R
doi: 10.1016/S2213-2600(26)00096-2
Asthma
Burden of Type 2 and Oral Corticosteroids Related Comorbidities in Severe Asthma Patients from the Gulf Countries: A Comparative Study from The ISAR Registry
J Asthma Allergy
Al-Ahmad M, Ali A, Al-Lehebi R, Mahboub B, Friston DA, Carter V, Scelo G, Bulathsinhala L, Beastall A, Price DB
doi: 10.2147/JAA.S555783
Asthma
Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma: The VESTIGE Trial
Am J Respir Crit Care Med
Porsbjerg C, Dunican EM, Lugogo NL, Castro M, Papi A, Backer V, Brightling CE, Bourdin A, Virchow JC, Zhang M, Soler X, Rowe PJ, Deniz Y, de Prado Gómez L, Sacks HJ, Jacob-Nara JA
doi: 10.1164/rccm.202410-1894OC
Asthma
Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study
Lancet Respir Med
Maspero JF, Pavord ID, Wechsler ME, Busse W, Laidlaw TM, Mróz RM, Liu T, Mikol V, Suratt BT, Gereige J, Mannent L, Martincova R
doi: 10.1016/S2213-2600(25)00439-4
Lung Cancer
LRP1B loss predicts sensitivity to immunotherapy in patients with NSCLC: an analysis of the phase 3 Checkmate 026 randomized trial
Clin Cancer Res
Armstrong AJ, Dietz H, Balli D, Geese WJ, Duan C, Hung YH, Ip V, Li G, Graf RP, Ready N
doi: 10.1158/1078-0432.CCR-25-0952
RECOMMENDED
COPD
TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: up to 12 months interim analysis
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Rohde G, Vogelmeier CF, Beeh KM, Kardos P, Paulsson T, Watz H, Westermayer B, Mohan T, Noorduyn SG, Claussen J
doi: 10.1016/j.rmed.2025.108597